Food Quality Vault Updated October 2026 Reference context: Codex Alimentarius
Executive Summary & Learning Objectives
Mycotoxins are toxic secondary metabolites synthesized by filamentous fungi under specific temperature and moisture conditions in cereal grains, oilseeds, nuts, and dried fruits. Because mycotoxins exhibit extreme resistance to industrial thermal processing, preventing their entry into food manufacturing supply chains requires rigorous incoming raw material screening. This module examines analytical extraction methodologies, immunoaffinity column cleanups, ELISA strip tests, and high-performance liquid chromatography tandem mass spectrometry (LC-MS/MS) quantification.
1. Major Mycotoxins and Chemical Toxicity Profiles
Industrial quality assurance protocols focus heavily on three primary mycotoxin classes:
Aflatoxins ($B_1$, $B_2$, $G_1$, $G_2$): Produced by Aspergillus flavus and A. parasiticus in corn, peanuts, and cottonseed. Aflatoxin $B_1$ is among the most potent natural liver carcinogens known.
Ochratoxin A (OTA): Synthesized by Penicillium verrucosum and Aspergillus ochraceus in stored wheat, barley, coffee beans, and wine grapes, acting as a potent nephrotoxin.
Fumonisins ($FB_1$, $FB_2$): Produced by Fusarium verticillioides in maize, disrupting sphingolipid biosynthesis and causing leukoencephalomalacia in equines and esophageal cancer risks in humans.
Figure 2.3 — Analytical Extraction and Cleanup Workflow for Mycotoxin Quantification
2. Analytical Methodologies: ELISA vs. LC-MS/MS
Screening protocols are split between rapid in-plant testing and confirmatory laboratory assays:
ELISA Strip Tests: Lateral flow immunoassays providing qualitative or semi-quantitative results within 5 to 10 minutes at grain intake receiving bays.
HPLC & LC-MS/MS: High-performance liquid chromatography coupled with tandem mass spectrometry provides definitive confirmation and multi-toxin separation down to sub-parts-per-billion limits.
3. Grain Silo Mitigation and Quality Assurance Management
Preventing mycotoxin accumulation in storage silos requires continuous relative humidity control ($RH < 70\%$), active aeration, and thermal monitoring. Shipments exceeding statutory limits (e.g., 20 ppb total aflatoxins for human food) must be segregated and rejected.
Incoming Raw Material Protocol
Representative sampling across bulk grain shipments utilizing spear samplers is mandatory. Composite samples must be thoroughly homogenized prior to rapid ELISA screening or LC-MS/MS verification.
Closing Summary & Regulatory Takeaways
Mycotoxin contamination poses severe health and economic risks across cereal and nut supply chains. Combining rapid lateral-Rapid screening and confirmatory LC-MS/MS can contribute to a mycotoxin control program when the methods are suitable for the commodity and analytes. They do not guarantee absolute compliance; sampling representativeness, method performance, legal limits and lot disposition also matter.
Frequently Asked Questions
What is the function of immunoaffinity column cleanup in mycotoxin extraction?
Immunoaffinity columns contain immobilized monoclonal antibodies specific to target mycotoxins. When grain extracts pass through, mycotoxins bind selectively while interfering food matrix components are washed away, yielding high-purity eluates for LC-MS/MS or HPLC analysis.
Why are fumonisins and ochratoxin A significant chemical hazards in cereal grain supply chains?
Fumonisins produced by Fusarium species disrupt sphingolipid metabolism and are classified as potential human carcinogens, while Ochratoxin A produced by Aspergillus and Penicillium is a potent nephrotoxin that accumulates in swine and human renal tissues.
Applied Case: Mycotoxin Screening (Aflatoxins, Ochratoxin A, Fumonisins)
This module focuses on mycotoxin screening (aflatoxins, ochratoxin a, fumonisins). A supplier or laboratory reports a chemical result inconsistent with the expected risk profile. Review sampling representativeness, recovery, matrix effects, uncertainty and confirmation criteria before accepting or rejecting the lot.
For this subject, distinguish the presence of a chemical from the risk assessment and the legal compliance decision. Confirm the exact substance, commodity, exposure route, analytical method and jurisdiction before applying a numerical threshold. Confirm the product, equipment and operating conditions that apply before transferring a concept into a local procedure. Treat examples as illustrations, not as universal limits or legal determinations.
Evidence and Decision Quality for Mycotoxin Screening (Aflatoxins, Ochratoxin A, Fumonisins)
Keep the current legal limit or action level, method validation and scope, sampling plan, recovery and uncertainty information, supplier records, confirmatory findings and documented risk decision. Detection alone does not establish the same risk or enforcement outcome for every substance.
For mycotoxin screening (aflatoxins, ochratoxin a, fumonisins), Record the decision owner, the criterion applied, the evidence reviewed, its limitations and the follow-up action. Cite the governing source and version where it affects the result.
Worked Application: Mycotoxin Screening (Aflatoxins, Ochratoxin A, Fumonisins)
Begin by identifying the exact substance and the decision to be made: screening, confirmation, exposure estimation, legal compliance, supplier approval or product disposition. A laboratory detection is only one part of the assessment. The relevant limit can differ by commodity, intended use, jurisdiction and effective date, and some contaminants are managed through action levels or other legal criteria rather than a single MRL.
Review the method’s scope, matrix effects, extraction recovery, calibration, uncertainty and reporting units. If the result is near a decision threshold, confirm whether the method is fit for that decision and whether confirmatory analysis is appropriate. Do not compare results generated by different methods as if their uncertainty and recovery were identical.
The final record should identify the source of the applicable limit, the sample and lot, the analytical method, the interpretation and the person authorizing the decision. Where the evidence does not resolve the risk, document the uncertainty and obtain qualified toxicological or regulatory review rather than inventing a universal threshold.
The stated scope for this module includes: Educational technical module covering mycotoxin screening, immunoaffinity column cleanup, ELISA strip testing, LC-MS/MS quantification, and grain silo mycotoxin mitigation strategies. The decision should be reproducible from the evidence and source version, with any uncertainty recorded explicitly.
Technical Interpretation and Control Logic: Mycotoxin Screening (Aflatoxins, Ochratoxin A, Fumonisins)
Separate hazard identification, exposure assessment, analytical detection and regulatory compliance. A detected substance is not interpreted using a universal threshold: the relevant rule can depend on substance, commodity, use, jurisdiction and date. Distinguish a screening result from a confirmed result and consider method scope, recovery, matrix interference and measurement uncertainty.
For food-contact materials or residues, document the intended use and exposure assumptions behind the assessment. Supplier documents can support traceability but should be checked for scope, manufacturer, material, use conditions and current regulatory status. Escalate ambiguous or borderline findings to qualified technical and regulatory personnel.
For this subject, distinguish the presence of a chemical from the risk assessment and the legal compliance decision. Confirm the exact substance, commodity, exposure route, analytical method and jurisdiction before applying a numerical threshold. Keep the rationale specific to the product, process and intended use; avoid implying universal compliance.
Identify the exact substance, commodity and jurisdiction.
Confirm whether the result is screening, confirmatory or quantitative.
Review method scope, recovery, uncertainty and the applicable limit.
Record the risk decision and the evidence supporting lot disposition.
Practical Review Questions: Mycotoxin Screening (Aflatoxins, Ochratoxin A, Fumonisins)
Use the following prompts to test the application of this topic to a real process. Answers should distinguish evidence from assumptions and legal obligations from preferred practice.
Which substance and commodity-specific legal limit or action level applies?
Does the analytical method support screening, confirmation or quantitative reporting?
How do matrix effects, recovery and uncertainty affect interpretation?
What additional evidence is needed before deciding lot disposition?
Conclusion and Recommended Next Step
Use this guide to support structured learning and review. Before applying the information at a real facility, confirm the current legal and customer requirements, consult the site's approved procedures, and document decisions through the responsible food-safety or quality process.
Technical Evidence & Practical Application
Starting points for independent verification. These links identify relevant public authorities; they do not mean that every claim on this page has been independently certified or that one jurisdiction’s rules apply everywhere.